pioneer 6 semaglutide SELECT Trial Frontiers | Cardiovascular Safety and
Description
GLP-1 (glucagon-like peptide-1) medications are a type of drug often used in weight loss and diabetes management

These medications mimic the action of the hormone GLP-1 (glucagon-like peptide-1), which helps manage blood sugar levels by stimulating insulin release, reducing glucagon secretion, and slowing gastric emptying
The gene therapy is specifically approved for those patients who currently use factor IX (FIX) prophylaxis therapy, or have current or historical life-threatening hemorrhage, or repeated, serious spontaneous bleeding episodes and do not have neutralizing antibodies to the adeno-associated virus serotype Rh74var (AAVRh74var) capsid

Safe, licensed compounded medications

[46] After completing the SURPASS-2 trial (NCT03987919), the company announced in April 2022 that tirzepatide had successfully met its clinical endpoints in obese and overweight participants without diabetes

We do see a lot of patients when they try to get off, unfortunately, then the weight comes back. Medi-Cal members younger than 21 will remain covered for purposes including weight loss, California officials said, citing a federal requirement
